Suppr超能文献

4-胍基-唾液酸烯丙酯与流感病毒神经氨酸酶复合物的三维结构

Three-dimensional structure of the complex of 4-guanidino-Neu5Ac2en and influenza virus neuraminidase.

作者信息

Varghese J N, Epa V C, Colman P M

机构信息

Biomolecular Research Institute, Parkville, Victoria, Australia.

出版信息

Protein Sci. 1995 Jun;4(6):1081-7. doi: 10.1002/pro.5560040606.

Abstract

The three-dimensional X-ray structure of a complex of the potent neuraminidase inhibitor 4-guanidino-Neu5Ac2en and influenza virus neuraminidase (Subtype N9) has been obtained utilizing diffraction data to 1.8 A resolution. The interactions of the inhibitor, solvent water molecules, and the active site residues have been accurately determined. Six water molecules bound in the native structure have been displaced by the inhibitor, and the active site residues show no significant conformational changes on binding. Sialic acid, the natural substrate, binds in a half-chair conformation that is isosteric to the inhibitor. The conformation of the inhibitor in the active site of the X-ray structure concurs with that obtained by theoretical calculations and validates the structure-based design of the inhibitor. Comparison of known high-resolution structures of neuraminidase subtypes N2, N9, and B shows good structural conservation of the active site protein atoms, but the location of the water molecules in the respective active sites is less conserved. In particular, the environment of the 4-guanidino group of the inhibitor is strongly conserved and is the basis for the antiviral action of the inhibitor across all presently known influenza strains. Differences in the solvent structure in the active site may be related to variation in the affinities of inhibitors to different subtypes of neuraminidase.

摘要

利用分辨率为1.8埃的衍射数据,已获得强效神经氨酸酶抑制剂4-胍基-Neu5Ac2en与流感病毒神经氨酸酶(N9亚型)复合物的三维X射线结构。已精确确定抑制剂、溶剂水分子和活性位点残基之间的相互作用。天然结构中结合的六个水分子已被抑制剂取代,且活性位点残基在结合时未显示出明显的构象变化。天然底物唾液酸以与抑制剂等排的半椅式构象结合。X射线结构活性位点中抑制剂的构象与理论计算结果一致,并验证了基于结构的抑制剂设计。对神经氨酸酶N2、N9和B亚型已知高分辨率结构的比较表明,活性位点蛋白质原子具有良好的结构保守性,但各个活性位点中水分子的位置保守性较差。特别是,抑制剂4-胍基的环境高度保守,这是该抑制剂对所有目前已知流感毒株具有抗病毒作用的基础。活性位点溶剂结构的差异可能与抑制剂对不同神经氨酸酶亚型亲和力的变化有关。

相似文献

引用本文的文献

3
Antiviral Approaches against Influenza Virus.抗流感病毒的策略。
Clin Microbiol Rev. 2023 Mar 23;36(1):e0004022. doi: 10.1128/cmr.00040-22. Epub 2023 Jan 16.
7
Antivirals Targeting the Neuraminidase.抗神经氨酸酶药物。
Cold Spring Harb Perspect Med. 2022 Jan 4;12(1):a038455. doi: 10.1101/cshperspect.a038455.

本文引用的文献

7
Structure of an escape mutant of glycoprotein N2 neuraminidase of influenza virus A/Tokyo/3/67 at 3 A.
J Mol Biol. 1988 Mar 5;200(1):201-3. doi: 10.1016/0022-2836(88)90344-0.
8
Three-dimensional structures of influenza virus neuraminidase-antibody complexes.流感病毒神经氨酸酶-抗体复合物的三维结构
Philos Trans R Soc Lond B Biol Sci. 1989 Jun 12;323(1217):511-8. doi: 10.1098/rstb.1989.0028.
10
MOPAC: a semiempirical molecular orbital program.MOPAC:一个半经验分子轨道程序。
J Comput Aided Mol Des. 1990 Mar;4(1):1-105. doi: 10.1007/BF00128336.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验